Rising awareness of rare metabolic disorders and improvements in newborn screening programs are reshaping the treatment landscape for phenylketonuria worldwide. Continuous advancements in therapeutic approaches and nutritional management are creating new opportunities for healthcare providers and biotechnology companies. The Phenylketonuria Treatment Market was valued at US$ 864.71 million in...